Back to top

Eli Lilly upgraded at HSBC after latest trial win for obesity pill

Eli Lilly upgraded at HSBC after latest trial win for obesity pill

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY)

Eli Lilly and Company (LLY)

Novo Nordisk A/S (NVO)